Puma Biotechnology
(NASDAQ) PBYI
Puma Biotechnology Financials at a Glance
Market Cap
$351.05M
Revenue (TTM)
$228.42M
Net Income (TTM)
$31.07M
EPS (TTM)
$0.61
P/E Ratio
11.30
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$6.92
Volume
13,167
Open
$6.62
Price
$6.92
Volume
13,167
Open
$6.62
Previous Close
$6.92
Daily Range
$6.56 - $6.98
52-Week Range
$2.58 - $7.68
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$6.92
Volume
13,167
Open
$6.62
Previous Close
$6.92
Daily Range
$6.56 - $6.98
52-Week Range
$2.58 - $7.68
PBYI News
PBYI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Puma Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
179
CEO
Alan H. Auerbach
Website
www.pumabiotechnology.comHeadquarters
Los Angeles, CA 90024, US
PBYI Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
16%
Net Income Margin
14%
Return on Equity
28%
Return on Capital
28%
Return on Assets
14%
Earnings Yield
8.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$351.05M
Shares Outstanding
50.88M
Volume
13.17K
Short Interest
0.00%
Avg. Volume
408.46K
Financials (TTM)
Gross Profit
$170.21M
Operating Income
$37.30M
EBITDA
$53.34M
Operating Cash Flow
$41.80M
Capital Expenditure
$71.00K
Free Cash Flow
$41.73M
Cash & ST Invst.
$97.53M
Total Debt
$28.55M
Puma Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$75.50M
+27.8%
Gross Profit
$52.30M
+15.8%
Gross Margin
69.27%
N/A
Market Cap
$351.05M
N/A
Market Cap/Employee
$2.04M
N/A
Employees
172
N/A
Net Income
$13.40M
-30.6%
EBITDA
$26.55M
+50.0%
Quarterly Fundamentals
Net Cash
$68.95M
+156.5%
Accounts Receivable
$53.65M
+67.6%
Inventory
$0.00
-100.0%
Long Term Debt
$4.71M
-79.7%
Short Term Debt
$23.84M
-53.1%
Return on Assets
14.37%
N/A
Return on Invested Capital
27.61%
N/A
Free Cash Flow
$14.46M
-7.3%
Operating Cash Flow
$14.42M
-7.6%